Millennium Management LLC grew its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 233.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 207,749 shares of the company's stock after purchasing an additional 145,359 shares during the quarter. Millennium Management LLC owned 0.51% of Phibro Animal Health worth $4,363,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in PAHC. Lazard Asset Management LLC lifted its stake in Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after acquiring an additional 1,589 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in Phibro Animal Health in the fourth quarter worth approximately $69,000. Quantbot Technologies LP lifted its stake in Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after acquiring an additional 2,018 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in Phibro Animal Health in the fourth quarter worth approximately $113,000. Finally, New York State Teachers Retirement System lifted its stake in Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after acquiring an additional 775 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.
Analyst Upgrades and Downgrades
PAHC has been the subject of several recent analyst reports. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health presently has a consensus rating of "Hold" and a consensus target price of $20.00.
Check Out Our Latest Report on PAHC
Phibro Animal Health Price Performance
Shares of NASDAQ:PAHC traded down $0.26 on Tuesday, reaching $24.32. 245,008 shares of the company were exchanged, compared to its average volume of 202,765. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a 1-year low of $16.16 and a 1-year high of $26.55. The firm has a market cap of $985.79 million, a price-to-earnings ratio of 50.67, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a 50-day moving average of $20.64 and a 200-day moving average of $21.87.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Equities analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.97%. Phibro Animal Health's payout ratio is currently 61.54%.
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
